Related references
Note: Only part of the references are listed.Quantification ofIn VivoMetabolic Activity ofCYP2D6Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine
Trine Frederiksen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Models of Idiosyncratic Drug-Induced Liver Injury
Tsuyoshi Yokoi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach
Vineet Kumar et al.
DRUG METABOLISM AND DISPOSITION (2021)
Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies
Kajsa P. Kanebratt et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Impact of Plasma Protein Binding in Drug Clearance Prediction: A DataBase Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation
L. J. Francis et al.
DRUG METABOLISM AND DISPOSITION (2021)
In Vitro Metabolism of Slowly Cleared G Protein-Coupled Receptor 139 Agonist TAK-041 Using Rat, Dog, Monkey, and Human Hepatocyte Models (HepatoPac): Correlation with In Vivo Metabolism
Amin Kamel et al.
DRUG METABOLISM AND DISPOSITION (2021)
Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation
Michael J. Doerksen et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2021)
Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model
Xiankang Fang et al.
LIFE SCIENCES (2021)
Pharmacokinetic changes of clozapine and norclozapine in a rat model of non-alcoholic fatty liver disease induced by orotic acid
Zhengri Li et al.
XENOBIOTICA (2021)
US FDA Approved Drugs from 2015-June 2020: A Perspective
Priyadeep Bhutani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Xenobiotic metabolism and transport in Caenorhabditis elegans
Jessica H. Hartman et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2021)
A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies
Ana S. Serras et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization
Jasleen K. Sodhi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
Christine Wegler et al.
MOLECULAR PHARMACEUTICS (2021)
Effect of Human Plasma on Hepatic Uptake of Organic Anion-Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes
Yi-An Bi et al.
DRUG METABOLISM AND DISPOSITION (2021)
A hybrid model to evaluate the impact of active uptake transport on hepatic distribution of atorvastatin in rats
Priyanka Kulkarni et al.
XENOBIOTICA (2020)
Pharmacokinetic and toxicodynamic evaluation of 5-fluorouracil administration after major hepatectomy in a rat model
Kazuhiro Tada et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity
Joanne X. Shen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Changes in Organic Anion Transporting Polypeptide Uptake in HEK293 Overexpressing Cells in the Presence and Absence of Human Plasma
Christine M. Bowman et al.
DRUG METABOLISM AND DISPOSITION (2020)
Different Roles of Human Cytochrome P450 2C9 and 3A Enzymes in Diclofenac 4′- and 5-Hydroxylations Mediated by Metabolically Inactivated Human Hepatocytes in Previously Transplanted Chimeric Mice
Tomonori Miura et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Establishment of a primary human hepatocyte spheroid system for evaluating metabolic toxicity using dacarbazine under conditions of CYP1A2 induction
Kenta Mizoi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2020)
Exploring interactions between xenobiotics, microbiota, and neurotoxicity in zebrafish
Luisa B. Bertotto et al.
NEUROTOXICOLOGY (2020)
Development of a generic zebrafish embryo PBPK model and application to the developmental toxicity assessment of valproic acid analogs
Segolene Simeon et al.
REPRODUCTIVE TOXICOLOGY (2020)
Towards harmonization of test methods for in vitro hepatic clearance studies
Jochem Louisse et al.
TOXICOLOGY IN VITRO (2020)
Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance
Erica L. Toth et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Are There Any Experimental Perfusion Data that Preferentially Support the Dispersion and Parallel-Tube Models over the Well-Stirred Model of Organ Elimination?
Jasleen K. Sodhi et al.
DRUG METABOLISM AND DISPOSITION (2020)
Effect of compromised liver function and acute kidney injury on the pharmacokinetics of thymoquinone in a rat model
Khalid M. Alkharfy et al.
XENOBIOTICA (2020)
Antibiotic-Driven Gut Microbiome Disorder Alters the Effects of Sinomenine on Morphine-Dependent Zebrafish
Zhu Chen et al.
FRONTIERS IN MICROBIOLOGY (2020)
Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism
Johanna Matilainen et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Evaluation of hepatic CYP2D1 activity and hepatic clearance in type I and type II diabetic rat models, before and after treatment with insulin and metformin
Navid Neyshaburinezhad et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Comparison of Fraction Unbound Between Liver Homogenate and Hepatocytes at 4°C
Keith Riccardi et al.
AAPS JOURNAL (2020)
Challenging the Relevance of Unbound Tissue-to-Blood Partition Coefficient (Kpuu) on Prediction of Drug-Drug Interactions
Jasleen K. Sodhi et al.
PHARMACEUTICAL RESEARCH (2020)
Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction
Kenichi Umehara et al.
DRUG METABOLISM AND DISPOSITION (2020)
Comparison of In Vitro to In Vivo Extrapolation Approaches for Predicting Transporter-Mediated Hepatic Uptake Clearance Using Suspended Rat Hepatocytes
Na Li et al.
DRUG METABOLISM AND DISPOSITION (2020)
Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways
Leslie Z. Benet et al.
AAPS JOURNAL (2020)
Anti-tuberculosis effect of isoniazid scales accurately from zebrafish to humans
Rob C. van Wijk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model
Jian Lu et al.
DRUG METABOLISM AND DISPOSITION (2020)
In Vitro Hepatic Uptake in Human and Monkey Hepatocytes in the Presence and Absence of Serum Protein and Its In Vitro to In Vivo Extrapolation
Xiaomin Liang et al.
DRUG METABOLISM AND DISPOSITION (2020)
Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance
Beth Williamson et al.
DRUG METABOLISM AND DISPOSITION (2020)
Zebrafish CYP1A expression in transgenic Caenorhabditis elegans protects from exposures to benzo[a]pyrene and a complex polycyclic aromatic hydrocarbon mixture
Jamie B. Harris et al.
TOXICOLOGY (2020)
CeMbio-TheCaenorhabditis elegansMicrobiome Resource
Philipp Dirksen et al.
G3-GENES GENOMES GENETICS (2020)
Roles of diclofenac and its metabolites in immune activation associated with acute hepatotoxicity in TgCYP3A4/hPXR-humanized mice
Weifan Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models
Kenta Mizoi et al.
BIOMEDICINES (2020)
Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research
Na Li et al.
AAPS JOURNAL (2020)
Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes
Christopher Keefer et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Animal models of drug-induced liver injury
Mitchell R. McGill et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Chlorpyrifos disturbs hepatic metabolism associated with oxidative stress and gut microbiota dysbiosis in adult zebrafish
Xiaoyu Wang et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2019)
The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation
Christine M. Bowman et al.
DRUG METABOLISM AND DISPOSITION (2019)
Application of New Cellular and Microphysiological Systems to Drug Metabolism Optimization and Their Positioning Respective to In Silico Tools
Luca Docci et al.
SLAS DISCOVERY (2019)
3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications
Volker M. Lauschke et al.
BIOTECHNOLOGY JOURNAL (2019)
The C. elegans intestine: organogenesis, digestion, and physiology
Ivan Dimov et al.
CELL AND TISSUE RESEARCH (2019)
Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016
Anitha Saravanakumar et al.
CLINICAL PHARMACOKINETICS (2019)
Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling
Go-Wun Choi et al.
PHARMACEUTICS (2019)
Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans
Mingxiang Liao et al.
XENOBIOTICA (2019)
The role of mouse tumour models in the discovery and development of anticancer drugs
Christopher R. Ireson et al.
BRITISH JOURNAL OF CANCER (2019)
The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs
Michel Bteich et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Liver organoids: from basic research to therapeutic applications
Nicole Prior et al.
GUT (2019)
Mechanistic and Quantitative Understanding of Pharmacokinetics in Zebrafish Larvae through Nanoscale Blood Sampling and Metabolite Modeling of Paracetamol
Rob C. Van Wijk et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
How Transporters Have Changed Basic Pharmacokinetic Understanding
Leslie Z. Benet et al.
AAPS JOURNAL (2019)
Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury
Yitian Zhou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Hepatic clearance concepts and misconceptions: Why the well-stirred model is still used even though it is not physiologic reality?
K. Sandy Pang et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the Albumin-Mediated Hepatic Uptake Mechanism on the Basis of the Facilitated-Dissociation Model
Soo-Jin Kim et al.
DRUG METABOLISM AND DISPOSITION (2019)
Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac (vol 41, pg 2024, 2013)
Tom S. Chan et al.
DRUG METABOLISM AND DISPOSITION (2019)
Use of Segregated Hepatocyte Scaling Factors and Cross-Species Relationships to Resolve Clearance Dependence in the Prediction of Human Hepatic Clearance
D. Hallifax et al.
DRUG METABOLISM AND DISPOSITION (2019)
A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation
Vineet Kumar et al.
DRUG METABOLISM AND DISPOSITION (2019)
The impact of antibiotic exposure in water and zebrafish gut microbiomes: A 16S rRNA gene-based metagenomic analysis
Ana Rita Almeida et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2019)
Microplastics induce intestinal inflammation, oxidative stress, and disorders of metabolome and microbiome in zebrafish
Ruxia Qiao et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2019)
The fruit fly Drosophila melanogaster as an innovative preclinical ADME model for solute carrier membrane transporters, with consequences for pharmacology and drug therapy
Yiwen Wang et al.
DRUG DISCOVERY TODAY (2018)
Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance
Tom De Bruyn et al.
DRUG METABOLISM AND DISPOSITION (2018)
Comparison of Species and Cell-Type Differences in Fraction Unbound of Liver Tissues, Hepatocytes, and Cell Lines
Keith Riccardi et al.
DRUG METABOLISM AND DISPOSITION (2018)
Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug Discovery
Paul Lancett et al.
DRUG METABOLISM AND DISPOSITION (2018)
The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model
Seiji Miyauchi et al.
DRUG METABOLISM AND DISPOSITION (2018)
Polystyrene microplastics induce microbiota dysbiosis and inflammation in the gut of adult zebrafish
Yuanxiang Jin et al.
ENVIRONMENTAL POLLUTION (2018)
Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes
Theresa Aliwarga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Inhibition of Organic Anion Transporting Polypeptide 1B1 and 1B3 by Betulinic Acid: Effects of Preincubation and Albumin in the Media
Yunseok Oh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding
Franck Da-silva et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes
Anna Vildhede et al.
MOLECULAR PHARMACEUTICS (2018)
Assessment of Transporter-Mediated and Passive Hepatic Uptake Clearance Using Rifamycin-SV as a Pan-Inhibitor of Active Uptake
Paresh P. Chothe et al.
MOLECULAR PHARMACEUTICS (2018)
Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study
Catherine C. Bell et al.
TOXICOLOGICAL SCIENCES (2018)
Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish
Manoochehr Khazaee et al.
ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS (2018)
The transcription factor SKN-1 and detoxification gene ugt-22 alter albendazole efficacy in Caenorhabditis elegans
Pauline Fontaine et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Drug metabolism in drug discovery and development
Zhoupeng Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance
Maciej J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
When Does the Rate-Determining Step in the Hepatic Clearance of a Drug Switch from Sinusoidal Uptake to All Hepatobiliary Clearances? Implications for Predicting Drug-Drug Interactions
Gabriela I. Patilea-Vrana et al.
DRUG METABOLISM AND DISPOSITION (2018)
Advances in Engineered Human Liver Platforms for Drug Metabolism Studies
Gregory H. Underhill et al.
DRUG METABOLISM AND DISPOSITION (2018)
An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation
C. M. Bowman et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Drug metabolism and metabolite safety assessment in drug discovery and development
Chunyong He et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Human liver spheroids in chemically defined conditions for studies of gene-drug, drug-drug and disease-drug interactions
Magnus Ingelman-Sundberg et al.
PHARMACOGENOMICS (2018)
Replacement, Refinement, and Reduction in Animal Studies With Biohazardous Agents
Lon Kendall et al.
ILAR JOURNAL (2018)
The Extended Clearance Concept Following Oral and Intravenous Dosing: Theory and Critical Analyses
Leslie Z. Benet et al.
PHARMACEUTICAL RESEARCH (2018)
Importance of the Unstirred Water Layer and Hepatocyte Membrane Integrity In Vitro for Quantification of Intrinsic Metabolic Clearance
Francesca L. Wood et al.
DRUG METABOLISM AND DISPOSITION (2018)
Humanizing the zebrafish liver shifts drug metabolic profiles and improves pharmacokinetics of CYP3A4 substrates
Kar Lai Poon et al.
ARCHIVES OF TOXICOLOGY (2017)
The C-elegans model in toxicity testing
Piper Reid Hunt
JOURNAL OF APPLIED TOXICOLOGY (2017)
On the Nature of Physiologically-Based Pharmacokinetic Models -A Priori or A Posteriori? Mechanistic or Empirical?
Ken Korzekwa et al.
PHARMACEUTICAL RESEARCH (2017)
Alternative Animal and Non-Animal Models for Drug Discovery and Development: Bonus or Burden?
Irlan Almeida Freires et al.
PHARMACEUTICAL RESEARCH (2017)
Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set
Tetsuo Yamagata et al.
XENOBIOTICA (2017)
Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics
Sabine U. Vorrink et al.
FASEB JOURNAL (2017)
Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches
Saki Izumi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Current In Vitro Methods to Determine Hepatic Kpuu: A Comparison of Their Usefulness and Limitations
Julia Riede et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro-In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs
Emi Kimoto et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Understanding the Interplay Between Uptake and Efflux Transporters Within In Vitro Systems in Defining Hepatocellular Drug Concentrations
Carina Cantrill et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism
Yukina Fukuchi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
In vitro CYP-mediated drug metabolism in the zebrafish (embryo) using human reference compounds
Moayad Saad et al.
TOXICOLOGY IN VITRO (2017)
Zebrafish as a Screening Model for Testing the Permeability of Blood-Brain Barrier to Small Molecules
Seong Soon Kim et al.
ZEBRAFISH (2017)
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Henrik H. Hansen et al.
DRUG DISCOVERY TODAY (2017)
Comparison of Methods for Estimating Unbound Intracellular-to-Medium Concentration Ratios in Rat and Human Hepatocytes Using Statins
Takashi Yoshikado et al.
DRUG METABOLISM AND DISPOSITION (2017)
Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes
Keith Riccardi et al.
DRUG METABOLISM AND DISPOSITION (2017)
Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans
Timothy A. Scott et al.
CELL (2017)
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling
Nicole A. Kratochwil et al.
AAPS JOURNAL (2017)
Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury
Catherine C. Bell et al.
DRUG METABOLISM AND DISPOSITION (2017)
Developmental Effects of the ToxCast™ Phase I and Phase II Chemicals in Caenorhabditis elegans and Corresponding Responses in Zebrafish, Rats, and Rabbits
Windy A. Boyd et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2016)
Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates
Volker M. Lauschke et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation
Volker M. Lauschke et al.
HEPATOLOGY (2016)
Drug Discovery in Fish, Flies, and Worms
Kevin Strange
ILAR JOURNAL (2016)
Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat
Tom De Bruyn et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research
Patrick Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Pharmacokinetic Modeling of Paracetamol Uptake and Clearance in Zebrafish Larvae: Expanding the Allometric Scale in Vertebrates with Five Orders of Magnitude
Vasudev Kantae et al.
ZEBRAFISH (2016)
Triclosan Exposure Is Associated with Rapid Restructuring of the Microbiome in Adult Zebrafish
Christopher A. Gaulke et al.
PLOS ONE (2016)
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
Catherine C. Bell et al.
SCIENTIFIC REPORTS (2016)
Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG
Britta Bonn et al.
DRUG METABOLISM AND DISPOSITION (2016)
Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes
Christine Lin et al.
DRUG METABOLISM AND DISPOSITION (2016)
Hepatic Clearance Predictions from In Vitro-In Vivo Extrapolation and the Biopharmaceutics Drug Disposition Classification System
Christine M. Bowman et al.
DRUG METABOLISM AND DISPOSITION (2016)
Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport
Priyanka Kulkarni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015
Matthew A. Cerny
DRUG METABOLISM AND DISPOSITION (2016)
Addressing the Challenges of Low Clearance in Drug Research
Li Di et al.
AAPS JOURNAL (2015)
15 years of zebrafish chemical screening
Andrew J. Rennekamp et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure
Anna Vildhede et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Translational value of mouse models in oncology drug development
Stephen E. Gould et al.
NATURE MEDICINE (2015)
D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?
Zofia Wańkowicz
MEDICAL SCIENCE MONITOR (2015)
Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists
J. Matthew Hutzler et al.
DRUG METABOLISM AND DISPOSITION (2015)
Meta-Analysis of Expression of Hepatic Organic Anion-Transporting Polypeptide (OATP) Transporters in Cellular Systems Relative to Human Liver Tissue
Justine Badee et al.
DRUG METABOLISM AND DISPOSITION (2015)
Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized Medicine
Rashmi R. Shah et al.
DRUG METABOLISM AND DISPOSITION (2015)
Interspecies Variability in Expression of Hepatobiliary Transporters across Human, Dog, Monkey, and Rat as Determined by Quantitative Proteomics
Li Wang et al.
DRUG METABOLISM AND DISPOSITION (2015)
In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications
Hyun-Jong Cho et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2014)
Evaluation of Human Hepatocytes Cultured by Three-dimensional Spheroid Systems for Drug Metabolism
Takako Ohkura et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
Using Drosophila melanogaster To Identify Chemotherapy Toxicity Genes
Elizabeth G. King et al.
GENETICS (2014)
Insights from the worm: The C. elegans model for innate immunity
Maria A. Ermolaeva et al.
SEMINARS IN IMMUNOLOGY (2014)
Effects of different pressure levels of CO2 pneumoperitoneum on liver regeneration after liver resection in a rat model
Yoko Komori et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Interindividual Variability in Hepatic Organic Anion-Transporting Polypeptides and P-Glycoprotein (ABCB1) Protein Expression: Quantification by Liquid Chromatography Tandem Mass Spectroscopy and Influence of Genotype, Age, and Sex
Bhagwat Prasad et al.
DRUG METABOLISM AND DISPOSITION (2014)
The Impact of Solute Carrier (SLC) Drug Uptake Transporter Loss in Human and Rat Cryopreserved Hepatocytes on Clearance Predictions
Patrik Lundquist et al.
DRUG METABOLISM AND DISPOSITION (2014)
Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver
X. Chu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery
Lee F. Willoughby et al.
DISEASE MODELS & MECHANISMS (2013)
Species differences in drug transporters and implications for translating preclinical findings to humans
Xiaoyan Chu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the In vitro-In vivo extrapolation methods: Emphasis on an apparent fraction unbound in liver for drugs
Patrick Poulin
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Application of In Silico, In Vitro and Preclinical Pharmacokinetic Data for the Effective and Efficient Prediction of Human Pharmacokinetics
Kenneth H. Grime et al.
MOLECULAR PHARMACEUTICS (2013)
The zebrafish reference genome sequence and its relationship to the human genome
Kerstin Howe et al.
NATURE (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Roles of the epoxygenase CYP2J2 in the endothelium
Ara Askari et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac
Tom S. Chan et al.
DRUG METABOLISM AND DISPOSITION (2013)
Toxicity ranking of heavy metals with screening method using adult Caenorhabditis elegans and propidium iodide replicates toxicity ranking in rat
Piper Reid Hunt et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs
Patrick Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Evaluation of hepatic clearance prediction using in vitro data: Emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs
David Hallifax et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
In vitro-in vivo extrapolation of clearance: Modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods
Patrick Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Translatability scoring in drug development: eight case studies
Alexandra Wendler et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes
Emi Kimoto et al.
MOLECULAR PHARMACEUTICS (2012)
Novel In Vitro-In Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat
Ken-ichi Umehara et al.
PHARMACEUTICAL RESEARCH (2012)
Effects of N1-methylnicotinamide on oxidative and glycooxidative stress markers in rats with streptozotocin-induced diabetes mellitus
Zuzana Orszaghova et al.
REDOX REPORT (2012)
Zebrafish embryos as an alternative to animal experiments-A commentary on the definition of the onset of protected life stages in animal welfare regulations
Uwe Straehle et al.
REPRODUCTIVE TOXICOLOGY (2012)
A Novel Relay Method for Determining Low-Clearance Values
Li Di et al.
DRUG METABOLISM AND DISPOSITION (2012)
Use of Mechanistic Modeling to Assess Interindividual Variability and Interspecies Differences in Active Uptake in Human and Rat Hepatocytes
Karelle Menochet et al.
DRUG METABOLISM AND DISPOSITION (2012)
An Investigation of the Bioactivation Potential and Metabolism Profile of Zebrafish versus Human
Hui Ting Chng et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data
Hannah M. Jones et al.
DRUG METABOLISM AND DISPOSITION (2012)
Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model
Karelle Menochet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Characterization of In Vitro Glucuronidation Clearance of a Range of Drugs in Human Kidney Microsomes: Comparison with Liver and Intestinal Glucuronidation and Impact of Albumin
Katherine L. Gill et al.
DRUG METABOLISM AND DISPOSITION (2012)
The reconstituted 'humanized liver' in TK-NOG mice is mature and functional
Masami Hasegawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs
Yoshiyuki Yabe et al.
DRUG METABOLISM AND DISPOSITION (2011)
Substitute of animals in drug research: An approach towards fulfillment of 4R′s
KK Sharma et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
The Corrected Traditional Equations for Calculation of Hepatic Clearance that Account for the Difference in Drug Ionization in Extracellular and Intracellular Tissue Water and the Corresponding Corrected PBPK Equation
Leonid M. Berezhkovskiy
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Study on possible mechanism of orotic acid-induced fatty liver in rats
Yu-Ming Wang et al.
NUTRITION (2011)
Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery
Udai Bhan Pandey et al.
PHARMACOLOGICAL REVIEWS (2011)
Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish
Jared V. Goldstone et al.
BMC GENOMICS (2010)
Application of In Vivo Animal Models to Characterize the Pharmacokinetic and Pharmacodynamic Properties of Drug Candidates in Discovery Settings
Benny M. Amore et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2010)
Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans
Takao Watanabe et al.
DRUG METABOLISM AND DISPOSITION (2010)
Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites
Wendy WeiWei Wang et al.
DRUG METABOLISM AND DISPOSITION (2010)
Network Analysis of Primary Hepatocyte Dedifferentiation Using a Shotgun Proteomics Approach
Cliff Rowe et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Males still dominate animal studies
Irving Zucker et al.
NATURE (2010)
Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View
David Hallifax et al.
PHARMACEUTICAL RESEARCH (2010)
A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay
Windy A. Boyd et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Optimising in vivo pharmacology studies-Practical PKPD considerations
Johan Gabrielsson et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Can Animal Models of Disease Reliably Inform Human Studies?
H. Bart van der Worp et al.
PLOS MEDICINE (2010)
Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development
Masato Chiba et al.
AAPS JOURNAL (2009)
Predicting Circulating Human Metabolites: How Good Are We?
Shelby Anderson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites
Deepak Dalvie et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Methodological Uncertainty in Quantitative Prediction of Human Hepatic Clearance from In Vitro Experimental Systems
D. Hallifax et al.
CURRENT DRUG METABOLISM (2009)
Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations
Johan Gabrielsson et al.
DRUG DISCOVERY TODAY (2009)
Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes
Peter J. Kilford et al.
DRUG METABOLISM AND DISPOSITION (2009)
Liver tissue engineering in the evaluation of drug safety
Ajit Dash et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
Takao Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Quantitative Pharmacology or Pharmacokinetic Pharmacodynamic Integration Should Be a Vital Component in Integrative Pharmacology
J. Gabrielsson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals
Carol Kilkenny et al.
PLOS ONE (2009)
Characterization of Drosophila melanogaster cytochrome P450 genes
Henry Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Comparison of intrinsic metabolic clearance in fresh and cryopreserved human hepatocytes
E. Floby et al.
XENOBIOTICA (2009)
Pharmacokinetic and pharmacodynamic data to be derived from early-phase drug development - Designing informative human pharmacology studies
Adam Cohen
CLINICAL PHARMACOKINETICS (2008)
Zebrafish: a predictive model for assessing drug-induced toxicity
Patricia McGrath et al.
DRUG DISCOVERY TODAY (2008)
The Albumin Effect and drug glucuronidation: Bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2008)
Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance
R. Stringer et al.
XENOBIOTICA (2008)
Zebrafish based assays for the assessment of cardiac, visual and gut function — potential safety screens for early drug discovery
Stéphane Berghmans et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2008)
Microscale culture of human liver cells for drug development
Salman R. Khetani et al.
NATURE BIOTECHNOLOGY (2008)
Rodent models of partial hepatectomies
Paulo N. A. Martins et al.
LIVER INTERNATIONAL (2008)
In vitro-in vivo extrapolation of hepatic clearance:: Biological tools, scaling factors, model assumptions and correct concentrations
O. Pelkonen et al.
XENOBIOTICA (2007)
Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo
Matthew G. Soars et al.
DRUG METABOLISM AND DISPOSITION (2007)
Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: Implications for in vitro-in vivo extrapolation
Andrew Rowland et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance
Hayley S. Brown et al.
DRUG METABOLISM AND DISPOSITION (2007)
Comparison of treatment effects between animal experiments and clinical trials: systematic review
Pablo Perel et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Specialized hepatocyte-like cells regulate Drosophila lipid metabolism
Eugenio Gutierrez et al.
NATURE (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro
M. Turpeinen et al.
XENOBIOTICA (2007)
Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements
Anna-Karin Sohlenius-Sternbeck
TOXICOLOGY IN VITRO (2006)
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Marcella Martignoni et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Prediction of hepatic clearance using cryopreserved human hepatocytes:: a comparison of serum and serum-free incubations
Nadege Blanchard et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Binding of drugs to hepatic microsomes: Comment and assessment of current prediction methodology with recommendation for improvement
D Hallifax et al.
DRUG METABOLISM AND DISPOSITION (2006)
Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance
N Hakooz et al.
PHARMACEUTICAL RESEARCH (2006)
Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells
S Neuhoff et al.
PHARMACEUTICAL RESEARCH (2006)
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes
RJ Riley et al.
DRUG METABOLISM AND DISPOSITION (2005)
The binding of drugs to hepatocytes and its relationship to physicochemical properties
RP Austin et al.
DRUG METABOLISM AND DISPOSITION (2005)
Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches
K Ito et al.
PHARMACEUTICAL RESEARCH (2005)
Prediction of in vitro intrinsic clearance from hepatocytes: Comparison of suspensions and monolayer cultures
SJ Griffin et al.
DRUG METABOLISM AND DISPOSITION (2005)
Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes
K Ito et al.
PHARMACEUTICAL RESEARCH (2004)
Where is the evidence that animal research benefits humans?
P Pound et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance
DF McGinnity et al.
DRUG METABOLISM AND DISPOSITION (2004)
Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes
N Blanchard et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver
ZE Wilson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism
A Westlind-Johnsson et al.
DRUG METABOLISM AND DISPOSITION (2003)
Functional and phylogenetic analyses of a putative Drosophila melanogaster UDP-glycosyltransferase gene
T Luque et al.
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: An application of serum incubation method
Y Shibata et al.
DRUG METABOLISM AND DISPOSITION (2002)
A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible
R Menzel et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man
JJP Bogaards et al.
XENOBIOTICA (2000)
Share Paper
